Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sub-cutaneous Ivermectin in Combination With and Without Oral Zinc: a Placebo Randomized Control Trial on Mild to Moderate COVID-19 Patients

NCT04472585 is registered in ClinicalTrials.gov with Sohaib Ashraf as lead sponsor.

NCT NCT04472585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04472585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sub-cutaneous Ivermectin in Combination With and Without Oral Zinc: a Placebo Randomized Control Trial on Mild to Moderate COVID-19 Patients
Lead sponsor
Sohaib Ashraf
Phase
Phase 1/2
Overall status
Unknown status
Start date
November 14, 2020
Completion date
October 30, 2021
Enrollment
180 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronavirus infection, covid, sars-cov2